FDA Approves Symbravo for Acute Treatment of Migraine in Adults By Lori Solomon HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...
Without a proper diagnosis, medications that can help reduce migraine may be delayed. Unfortunately, our study found racial and ethnic disparities in the diagnosis, testing and treatment of migraine." ...
Migraine with brainstem aura or MBA (formerly known as basilar migraines) are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness ...
The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...
NEW YORK, Jan 24 (Reuters) - Pfizer (PFE.N), opens new tab will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
